Canopy Growth (CGC) Operating Income (2019 - 2026)
Canopy Growth (CGC) posted Operating Income of -$47.2 million for Q4 2025, down 284.77% sequentially from -$12.3 million in Q3 2025, and down 176.98% YoY from $61.4 million in Q4 2024.
Canopy Growth (CGC) Operating Income (2019 - 2026) Analysis & Trends
Canopy Growth has reported Operating Income for 7 years, with the latest figure at -$47.2 million in Q4 2025.
- Quarterly Operating Income fell 176.98% year-over-year to -$47.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$92.9 million (up 38.58% YoY) and the FY2026 annual result came in at -$117.9 million, down 44.4% from the prior year.
- Operating Income eased to -$47.2 million in Q4 2025 per CGC's latest filing, from -$12.3 million in the prior quarter.
- Over five years, Operating Income peaked at -$5.2 million in Q3 2023 and troughed at -$1.4 billion in Q2 2022.
- A 5-year average of -$176.7 million and a median of -$79.2 million in 2024 frame the typical range for Operating Income.
- The sharpest annual moves came in 2022 and 2023: Operating Income slumped 846.31% in 2022, then soared 97.18% in 2023.
- Over 5 years, Operating Income stood at -$119.0 million in 2021, then jumped by 30.22% to -$83.0 million in 2022, then surged by 46.63% to -$44.3 million in 2023, then soared by 61.51% to -$17.1 million in 2024, then slumped by 176.98% to -$47.2 million in 2025.
- According to Business Quant data, Operating Income over the past three periods registered -$47.2 million, -$12.3 million, and -$16.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Canopy Growth | 432.82 Mn | 185.81 Mn | 16.08 Mn | -15.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -15.98 Mn |
| Dec 31, 2025 | -47.23 Mn |
| Sep 30, 2025 | -12.28 Mn |
| Jun 30, 2025 | -16.33 Mn |
| Dec 31, 2024 | -17.05 Mn |
| Sep 30, 2024 | -33.68 Mn |
| Jun 30, 2024 | -21.28 Mn |
| Mar 31, 2024 | -79.21 Mn |
| Dec 31, 2023 | -44.30 Mn |
| Sep 30, 2023 | -5.23 Mn |
| Jun 30, 2023 | -40.69 Mn |
| Mar 31, 2023 | -402.97 Mn |
| Dec 31, 2022 | -83.02 Mn |
| Sep 30, 2022 | -114.38 Mn |
| Jun 30, 2022 | -1.45 Bn |
| Mar 31, 2022 | -367.71 Mn |
| Dec 31, 2021 | -118.97 Mn |
| Sep 30, 2021 | -171.08 Mn |
| Jun 30, 2021 | -152.71 Mn |
| Mar 31, 2021 | -184.25 Mn |